The Global Insulin Pen Needles Market was valued at USD 1274 million in 2023 and is projected to reach USD 2116.12 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.80% during the forecast period (2023–2032). This growth is being driven by the rising prevalence of diabetes worldwide, increasing preference for self-injection devices among patients, and the growing emphasis on safety features to prevent needlestick injuries in both home and clinical environments.
As the diabetes management sector advances toward more user-friendly and secure injection solutions, attention turns to the leading manufacturers who are pioneering innovations in needle design, materials, and compatibility with pen devices. In this blog, we profile the Top 10 Companies in the Insulin Pen Needles Industry—a blend of established medical device leaders, pharmaceutical-integrated suppliers, and specialized innovators redefining accessible and effective insulin delivery.
🔟 1. BD (Becton, Dickinson and Company)
Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: BD Nano 4mm Pen Needles, BD Ultra-Fine, SafetyGlide Shielding Needles
BD stands as a global powerhouse in medical devices, with a dominant presence in the insulin pen needles segment. The company provides a wide array of needles designed for compatibility with most insulin pens, catering to patients requiring precise and comfortable injections. Their products emphasize reduced pain through ultra-fine gauges and shorter lengths, serving millions of diabetes patients across home care and healthcare facilities. BD’s commitment to quality is evident in their adherence to stringent ISO standards and ongoing research into ergonomic designs that enhance user adherence.
Key Innovations:
-
Development of the BD Nano series for minimal tissue trauma
-
Safety-engineered needles to minimize injury risks in professional settings
-
Partnerships with diabetes associations for patient education programs
Download FREE Sample Report: Insulin Pen Needles Market – View in Detailed Research Report
9️⃣ 2. Novo Nordisk
Headquarters: Bagsværd, Denmark
Key Offering: NovoFine Plus Needles, NovoTwist, Compatibility with NovoPen Devices
Novo Nordisk, a leader in diabetes therapeutics, extends its expertise into insulin pen needles through integrated solutions that pair seamlessly with their insulin pens. These needles are engineered for ease of use, featuring options in various lengths and gauges to suit individual patient needs. The company’s focus on end-to-end diabetes management has made their needles a staple in both self-administration and clinical protocols, with particular emphasis on regions experiencing rapid diabetes growth like Asia-Pacific.
Key Innovations:
-
Twist-off designs for quick and hygienic attachment
-
Collaboration with healthcare providers to optimize needle selection
-
Investments in biodegradable materials for eco-friendly disposal
8️⃣ 3. Terumo Corporation
Headquarters: Tokyo, Japan
Key Offering: Nanopass Needles, Ultra-Short 4mm Options, Safety-Engineered Variants
Terumo excels in precision-engineered insulin pen needles that prioritize patient comfort and injection accuracy. Their portfolio includes advanced silicone-coated needles to reduce friction and pain, making them ideal for frequent users. With a strong foothold in the Asia-Pacific market, Terumo supplies needles to hospitals, clinics, and home users, driving improvements in diabetes control through reliable performance and compatibility with universal pen systems.
Key Innovations:
-
Electro-polished tips for smoother skin penetration
-
Expansion into emerging markets with affordable needle options
-
R&D in needle-hub integration for leak-proof delivery
7️⃣ 4. B. Braun Melsungen AG
Headquarters: Melsungen, Germany
Key Offering: Sterican Insulin Pen Needles, Insuman Compatible, Safety Mechanisms
B. Braun brings decades of experience in medical disposables to the insulin pen needles market, offering high-quality, sterile needles that meet European and global regulatory standards. Their products are widely used in medical institutions for their durability and ease of handling, while also supporting home care through user-friendly packaging. The company’s emphasis on safety has positioned it as a trusted partner for healthcare professionals managing diabetes in diverse settings.
Key Innovations:
-
Integrated shielding to prevent accidental pricks
-
Customization for pediatric and geriatric patients
Download FREE Sample Report: Insulin Pen Needles Market – View in Detailed Research Report
6️⃣ 5. Ypsomed Holding AG
Headquarters: Burgdorf, Switzerland
Key Offering: mylife Penfine Needles, Unifine, Safety Auto-Inject Variants
Ypsomed specializes in drug delivery systems, including a robust line of insulin pen needles that integrate with their own injection devices for optimal performance. These needles feature thin walls for faster insulin flow and are designed to minimize dosing errors. With a focus on innovation, Ypsomed serves both consumer and institutional markets, contributing to better glycemic control through reliable and comfortable injection experiences.
Key Innovations:
-
Color-coded sizes for easy identification
-
Development of app-connected pens with needle compatibility
5️⃣ 6. Owen Mumford Ltd.
Headquarters: Woodstock, Oxfordshire, UK
Key Offering: Unifine Pentips, AutoSleeve Safety Needles, Varied Gauge Options
Owen Mumford is renowned for its safety-focused insulin pen needles, which incorporate automatic shielding to protect users from injuries. Their products are popular in home use settings, where patient safety is paramount, and are backed by clinical studies demonstrating reduced pain levels. The company’s European heritage ensures compliance with high safety norms, making it a preferred choice for diabetes self-management programs.
Key Innovations:
-
One-handed activation safety features
-
Extensive clinical trials for efficacy validation
4️⃣ 7. Artsana Group (Pic Solution)
Headquarters: Grandate, Italy
Key Offering: Pic Indolor Needles, FinePoint, Standard and Safety Types
Artsana, through its Pic brand, delivers affordable yet high-quality insulin pen needles tailored for global distribution. Their needles emphasize comfort with laser-bevel tips and are compatible with a broad range of pens, appealing to cost-conscious markets in Europe and beyond. By focusing on accessibility, Artsana supports widespread adoption of pen-based insulin therapy in daily diabetes care.
Key Innovations:
-
Cost-effective manufacturing for developing regions
-
Patient feedback-driven design improvements
Download FREE Sample Report: Insulin Pen Needles Market – View in Detailed Research Report
3️⃣ 8. Ulticare Inc.
Headquarters: Laguna Niguel, California, USA
Key Offering: UltiCare Pen Needles, SureComfort, Veterinary-Compatible Variants
Ulticare provides specialized insulin pen needles that extend to both human and veterinary applications, with a strong emphasis on precision and comfort. Their products feature proprietary coatings for smoother injections and are distributed through pharmacies and online platforms, facilitating easy access for home users. Ulticare’s niche in affordable, reliable needles has helped expand self-care options in North America.
Key Innovations:
-
Electrolytically sharpened tips for reduced penetration force
-
Bulk packaging for frequent users
2️⃣ 9. Promisemed
Headquarters: Anyang, South Korea
Key Offering: Promisemed Safety Needles, Micro-Fine Options, Institutional Supplies
Promisemed emerges as a key Asian player in insulin pen needles, offering safety-oriented designs that comply with international standards. Their needles are engineered for minimal tissue disruption and are increasingly adopted in medical institutions across Asia-Pacific. With investments in local production, Promisemed addresses regional demands for cost-effective, high-volume supplies while advancing safety protocols.
Key Innovations:
-
Anti-coring technology to prevent fragment risks
-
Expansion into smart needle sensors
1️⃣ 10. Jiangsu Jichun Medical Technology Co., Ltd.
Headquarters: Changzhou, Jiangsu, China
Key Offering: Jichun Pen Needles, Standard and Safety Types, OEM Services
Jiangsu Jichun leads in China’s insulin pen needles production, supplying both domestic and export markets with versatile, high-quality options. Their portfolio includes customizable needles for various pen brands, focusing on scalability and affordability to meet growing diabetes needs in emerging economies. As an OEM provider, they support global brands while innovating in manufacturing efficiency.
Key Innovations:
-
Automated production for consistent quality
-
Strategic exports to support international supply chains
Read Full Report: Insulin Pen Needles Market – View in Detailed Research Report
🌍 Outlook: The Future of Insulin Pen Needles Is Safer and More Accessible
The insulin pen needles market is experiencing significant evolution. While standard needles remain prevalent, the sector is channeling resources into advanced safety mechanisms, finer gauges for comfort, and sustainable manufacturing to address rising diabetes cases projected to reach 700 million globally by 2045. This shift not only improves patient outcomes but also aligns with healthcare policies promoting self-management.
📈 Key Trends Shaping the Market:
-
Growing adoption of safety needles to comply with needlestick prevention regulations
-
Expansion in home-use segments driven by telemedicine and patient empowerment
-
Innovation in ultra-short, thin-wall needles for painless injections
-
Regional growth in Asia-Pacific and Latin America due to urbanization and awareness campaigns
Market Trends Shaping Insulin Pen Needles
-
Rise of Safety-Engineered Designs — With needlestick injuries costing healthcare systems billions, manufacturers are prioritizing automatic shielding and retractable mechanisms. BD and B. Braun lead with products that reduce risks by up to 90% in clinical trials.
-
Focus on Patient Comfort and Adherence — Shorter needles (4-6mm) and silicone coatings minimize pain, encouraging regular use among type 2 diabetes patients. Studies show a 20% adherence boost with comfortable options from Terumo and Novo Nordisk.
-
Integration with Digital Health Tools — Needles compatible with smart pens for dose logging via apps are gaining traction, especially among younger demographics. Ypsomed’s mylife ecosystem exemplifies this connectivity trend.
-
Sustainable and Cost-Effective Production — Eco-friendly materials and efficient manufacturing from Chinese firms like Jiangsu Jichun lower costs, making needles accessible in low-income regions while reducing environmental impact.
-
Expansion in Emerging Markets — Rising diabetes prevalence in India and Brazil drives demand for affordable variants. OEM partnerships enable global players to scale production without compromising quality.
Read Full Report: Insulin Pen Needles Market – View in Detailed Research Report
The companies listed above are not only supplying essential insulin pen needles—they’re spearheading the advancements in patient-centered diabetes care.